Thanks for sharing your insight. I’m not familiar with the details of the patents so it’s good to learn that Dr. Cristofanilli shares the patents and is still with CYDY and will move the cancer trials forward.

IMO, the conference call next week is crucial for the near term settlement and SP of CYDY. Yes, HIV is still moving forward s planned but the cancer potential brought many new investors on board and got older investors to invest more (including myself). The mTNBC trial is so far delayed that I’m not sure if we can even call it a delay anymore. These issues better be discussed and clarified on Tuesday or we may see the low .30s soon.